Skip to main content

Angiodynamics Inc DEF 14A, filed Oct 8, 2026

Angiodynamics Inc (ANGO)

DEF 14A 2026-10-08 For: 2026-11-17
View Original
Added on October 08, 2026

About this DEF 14A

Angiodynamics Inc filed this DEF 14A on October 8, 2026.

AngioDynamics will ask shareholders at its November 17, 2026 virtual annual meeting to elect two Class II directors, ratify Deloitte & Touche LLP, approve executive compensation and increase the 2020 Equity Incentive Plan reserve from 9,050,000 to 10,050,000 shares. AI summary